Study side effects of cancer treatment in localized breast or lung cancer
Treatments studied
Part of Cancer, Lungs & breathing, Skin clinical trials.
This study looks at long-term side effects from standard cancer treatments and how they affect daily life and resources. It may help improve care for people with breast or lung cancer that has not spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (18+) and able to participate with consent
- Have breast cancer (localized) or lung cancer (localized, not spread) confirmed by lab testing
- Have no known metastasis at the start of the study
- Not be currently receiving active breast or lung cancer treatment when enrolling
- For breast cancer: be fluent in French and willing to provide extra blood/tissue samples and complete questionnaires
- For lung cancer: be eligible for curative surgery or radiotherapy (not only chemotherapy or only radiotherapy methods)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This trial collects blood and tissue samples from people newly diagnosed with lung cancer (NSCLC or CPC) to study the disease over time. It helps researchers understand how different treatments affect the cancer and the body.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This study collects medical data and samples from people with newly diagnosed bronchial cancer to learn more about the disease. You may be able to join if you have not yet started treatment for this cancer.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study collects blood and tissue samples from people with non-small cell lung cancer (NSCLC) either before or after treatment. It aims to help researchers learn more about how tumors respond, especially in cancers with specific genetic changes or after certain pre-surgery therapies.
Hear when a new Early Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.